Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration

Daniel Barthelmes; Anna Campain; Phuc Nguyen; Jennifer J Arnold; Ian L McAllister; Judy M Simpson; Alex P Hunyor; Robyn Guymer; Rohan W Essex; Nigel Morlet; Mark C Gillies

doi:10.1136/bjophthalmol-2015-308090

Article info

Clinical science

Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration

Authors

Daniel Barthelmes The Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, Switzerland PubMed articles Google scholar articles
Anna Campain The Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articles Google scholar articles
Phuc Nguyen The Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articles Google scholar articles
Jennifer J Arnold Marsden Eye Specialists, Parramatta, Australia PubMed articles Google scholar articles
Ian L McAllister The Lions Eye Institute, Center for Ophthalmology and Vision Science, University of Western Australia, Perth, Western Australia, Australia PubMed articles Google scholar articles
Judy M Simpson Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia PubMed articles Google scholar articles
Alex P Hunyor The Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia Retina Associates, Chatswood, New South Wales, Australia PubMed articles Google scholar articles
Robyn Guymer Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Rohan W Essex Department of Ophthalmology, Canberra Hospital, Garran, Australian Capital Territory, Australia PubMed articles Google scholar articles
Nigel Morlet Department of Population Health, University of Western Australia, Perth, Western Australia, Australia PubMed articles Google scholar articles
Mark C Gillies The Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articles Google scholar articles

Correspondence to Dr Daniel Barthelmes, Department of Ophthalmology University Hospital Zurich Frauenklinikstrasse 24, Zurich 8091, Switzerland; dbar8165{at}uni.sydney.edu.au

View Full Text

Citation

Barthelmes D, Campain A, Nguyen P for the Fight Retinal Blindness! Project Investigators, et al

Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration

British Journal of Ophthalmology 2016;100:1640-1645.

Publication history

Received November 12, 2015
Revised February 13, 2016
Accepted February 22, 2016
First published March 18, 2016.

Online issue publication

February 19, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password